These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 799523)

  • 1. Human centromere mapping using teratoma data.
    Ott J; Hecht F; Linder D; Lovrien EW; McCaw BK
    Birth Defects Orig Artic Ser; 1976; 12(7):396-8. PubMed ID: 799523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating distances from the centromere by means of benign ovarian teratomas in man.
    Ott J; Linder D; McCaw BK; Lovrien EW; Hecht F
    Ann Hum Genet; 1976 Nov; 40(2):191-6. PubMed ID: 1015813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics and biology of human ovarian teratomas. II. Molecular analysis of origin of nondisjunction and gene-centromere mapping of chromosome I markers.
    Deka R; Chakravarti A; Surti U; Hauselman E; Reefer J; Majumder PP; Ferrell RE
    Am J Hum Genet; 1990 Oct; 47(4):644-55. PubMed ID: 1977308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse origins of multiple ovarian teratomas in a single individual.
    Carritt B; Parrington JM; Welch HM; Povey S
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7400-4. PubMed ID: 6961419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The origin of ovarian teratomas.
    Parrington JM; West LF; Povey S
    J Med Genet; 1984 Feb; 21(1):4-12. PubMed ID: 6363699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and biology of human ovarian teratomas. I. Cytogenetic analysis and mechanism of origin.
    Surti U; Hoffner L; Chakravarti A; Ferrell RE
    Am J Hum Genet; 1990 Oct; 47(4):635-43. PubMed ID: 2220805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-centromere mapping and the study of non-disjunction in autosomal trisomies and ovarian teratomas.
    Chakravarti A; Majumder PP; Slaugenhaupt SA; Deka R; Warren AC; Surti U; Ferrell RE; Antonarakis SE
    Prog Clin Biol Res; 1989; 311():45-79. PubMed ID: 2771999
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of the ovarian teratoma mapping method in the mouse.
    Eppig JT; Eicher EM
    Genetics; 1983 Apr; 103(4):797-812. PubMed ID: 6852526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human gene mapping by postreduction and recombination frequencies under complete interference.
    Ott J
    Clin Genet; 1979 Jan; 15(1):11-6. PubMed ID: 759051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of recombination in the centromere region of mouse chromosome 7 using ovarian teratoma and backcross methods.
    Eppig JT; Eicher EM
    J Hered; 1988; 79(6):425-9. PubMed ID: 3209850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics and biology of human ovarian teratomas. III. Cytogenetics and origins of malignant ovarian germ cell tumors.
    Hoffner L; Shen-Schwarz S; Deka R; Chakravarti A; Surti U
    Cancer Genet Cytogenet; 1992 Aug; 62(1):58-65. PubMed ID: 1521236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine ovarian teratomas and parthenotes as cytogenetic tools.
    Eicher EM
    Cytogenet Cell Genet; 1978; 20(1-6):232-9. PubMed ID: 648179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why are ovarian teratomas benign whilst teratomas of the testis are malignant?
    Riley PA; Sutton PM
    Lancet; 1975 Jun; 1(7921):1360-2. PubMed ID: 48948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matching maternal isodisomy in mucinous carcinomas and associated ovarian teratomas provides evidence of germ cell derivation for some mucinous ovarian tumors.
    Kerr SE; Flotte AB; McFalls MJ; Vrana JA; Halling KC; Bell DA
    Am J Surg Pathol; 2013 Aug; 37(8):1229-35. PubMed ID: 23774174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian teratomas: cytologic data.
    McCaw BK; Hecht F; Linder D; Lovrien EW; Wyandt H; Bacon D; Clark B; Lea N
    Cytogenet Cell Genet; 1976; 16(1-5):391-5. PubMed ID: 975915
    [No Abstract]   [Full Text] [Related]  

  • 16. Mature cystic teratomas arise from meiotic oocytes, but not from pre-meiotic oogonia.
    Kaku H; Usui H; Qu J; Shozu M
    Genes Chromosomes Cancer; 2016 Apr; 55(4):355-64. PubMed ID: 26791142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign ovarian teratomas. An analysis of their cellular origin.
    Dahl N; Gustavson KH; Rune C; Gustavsson I; Pettersson U
    Cancer Genet Cytogenet; 1990 May; 46(1):115-23. PubMed ID: 1970513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian mucinous tumors arising from mature cystic teratomas--a molecular genetic approach for understanding the cellular origin.
    Fujii K; Yamashita Y; Yamamoto T; Takahashi K; Hashimoto K; Miyata T; Kawai K; Kikkawa F; Toyokuni S; Nagasaka T
    Hum Pathol; 2014 Apr; 45(4):717-24. PubMed ID: 24485845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parthenogenic origin of benign ovarian teratomas.
    Linder D; McCaw BK; Hecht F
    N Engl J Med; 1975 Jan; 292(2):63-6. PubMed ID: 162806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial occurrence of mature ovarian teratomas.
    Simon A; Ohel G; Neri A; Schenker JG
    Obstet Gynecol; 1985 Aug; 66(2):278-9. PubMed ID: 4022488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.